Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
JAMA Cardiol. 2021 Feb 1;6(2):189-198. doi: 10.1001/jamacardio.2020.5268.
Volumetric measurements by transthoracic echocardiogram may better reflect left ventricular (LV) remodeling than conventional linear LV dimensions. However, the association of LV volumes with mortality in patients with chronic hemodynamically significant aortic regurgitation (AR) is unknown.
To assess whether LV volumes and volume-derived LV ejection fraction (Vol-LVEF) are determinants of mortality in AR.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study included consecutive asymptomatic patients with chronic moderately severe to severe AR from a tertiary referral center (January 2004 through April 2019).
Clinical and echocardiographic data were analyzed retrospectively. Aortic regurgitation severity was graded by comprehensive integrated approach. De novo disk-summation method was used to derive LV volumes and Vol-LVEF.
Associations between all-cause mortality under medical surveillance and the following LV indexes: linear LV end-systolic dimension index (LVESDi), linear LVEF, LV end-systolic volume index (LVESVi), and Vol-LVEF.
Of 492 asymptomatic patients (mean [SD] age, 60 [17] years; 425 men [86%]), ischemic heart disease prevalence was low (41 [9%]), and 453 (92.1%) had preserved linear LVEF (≥50%) with mean (SD) LVESVi of 41 (15) mL/m2. At a median (interquartile range) of 5.4 (2.5-10.1) years, 66 patients (13.4%) died under medical surveillance; overall survival was not different than the age- and sex-matched general population (P = .55). Separate multivariate models, adjusted for age, sex, Charlson Comorbidity Index, and AR severity, demonstrated that in addition to linear LVEF and LVESDi, LVESVi and Vol-LVEF were independently associated with mortality under surveillance (all P < .046) with similar C statistics (range, 0.83-0.84). Spline curves showed that continuous risks of death started to rise for both linear LVEF and Vol-LVEF less than 60%, LVESVi more than 40 to 45 mL/m2, and LVESDi above 21 to 22 mm/m2. As dichotomized variables, patients with LVESVi more than 45 mL/m2 exhibited increased relative death risk (hazard ratio, 1.93; 95% CI, 1.10-3.38; P = .02) while LVESDi more than 20 mm/m2 did not (P = .32). LVESVi more than 45 mL/m2 showed a decreased survival trend compared with expected population survival.
In this large asymptomatic cohort of patients with hemodynamically significant AR, LVESVi and Vol-LVEF worked equally as well as LVESDi and linear LVEF in risk discriminating patients with excess mortality. A LVESVi threshold of 45 mL/m2 or greater was significantly associated with an increased mortality risk.
经胸超声心动图的容积测量可能比传统的线性左心室(LV)尺寸更能反映 LV 重构。然而,慢性血流动力学显著主动脉瓣反流(AR)患者的 LV 容积与死亡率之间的关系尚不清楚。
评估 LV 容积和容积衍生的 LV 射血分数(Vol-LVEF)是否是 AR 患者死亡率的决定因素。
设计、地点和参与者:这项队列研究包括来自三级转诊中心的连续无症状慢性中度至重度 AR 患者(2004 年 1 月至 2019 年 4 月)。
回顾性分析临床和超声心动图数据。采用综合综合方法对 AR 严重程度进行分级。采用新的圆盘求和法得出 LV 容积和 Vol-LVEF。
所有原因死亡率在医疗监测下与以下 LV 指标之间的相关性:线性 LV 收缩末期尺寸指数(LVESDi)、线性 LVEF、LV 收缩末期容积指数(LVESVi)和 Vol-LVEF。
在 492 名无症状患者(平均[标准差]年龄 60[17]岁;425 名男性[86%])中,缺血性心脏病患病率较低(41[9%]),453 名(92.1%)具有保留的线性 LVEF(≥50%),平均(标准差)LVESVi 为 41[15]mL/m2。在中位数(四分位间距)5.4(2.5-10.1)年的随访中,66 名患者(13.4%)在医疗监测下死亡;总生存率与年龄和性别匹配的一般人群无差异(P=0.55)。分别调整年龄、性别、Charlson 合并症指数和 AR 严重程度的多变量模型表明,除了线性 LVEF 和 LVESDi 外,LVESVi 和 Vol-LVEF 也与监测下的死亡率独立相关(所有 P<0.046),C 统计值相似(范围,0.83-0.84)。样条曲线显示,线性 LVEF 和 Vol-LVEF 小于 60%、LVESVi 大于 40 至 45 mL/m2 和 LVESDi 大于 21 至 22 mm/m2 时,死亡的连续风险开始上升。作为二分类变量,LVESVi 大于 45 mL/m2 的患者死亡的相对风险增加(危险比,1.93;95%CI,1.10-3.38;P=0.02),而 LVESDi 大于 20 mm/m2 的患者则没有(P=0.32)。与预期人群的生存率相比,LVESVi 大于 45 mL/m2 显示出生存率下降的趋势。
在这项大型无症状慢性血流动力学显著 AR 患者队列中,LVESVi 和 Vol-LVEF 与 LVESDi 和线性 LVEF 一样能够很好地区分死亡率过高的患者。LVESVi 阈值大于 45 mL/m2 与死亡率增加显著相关。